Artelo Biosciences

About Artelo Biosciences

Artelo Biosciences is focused on modifying lipid-signaling pathways to improve treatments for people living with cancer, aiming to advance scientific approaches in this area.

Products & Services

ART27.13:A product in the pipeline, specifics not detailed in the content.

ART27.13

ART26.12

ART12.11

Specialties

Lipid-signaling pathways Cancer treatment development Cancer treatments

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Private Placement T: - FT: Private Placement	A: 11000000 MR: - FA: approximately $11.0 million FAN: 11000000	D: 2026-03-30 FD: 2026-03-30	-
2	RT: Private Placement T: - FT: Private Placement	A: 11000000 MR: - FA: $11.0 million FAN: 11000000	D: 2026-03-27 FD: 2026-03-27	-
3	RT: Public Offering T: - FT: Public Offering	A: 2000000 MR: - FA: $2.0 million FAN: 2000000	D: 2025-10-01 FD: 2025-10-01	1 investors
4	RT: Public Offering T: - FT: Public Offering	A: 2000000 MR: - FA: $2.0 million FAN: 2000000	D: 2025-09-30 FD: 2025-09-30	1 investors
5	RT: Public Offering T: - FT: Public Offering	A: 3000000 MR: - FA: 3.0 Million FAN: 3000000	D: 2025-09-05 FD: 2025-09-05	1 investors
6	RT: Public Offering T: - FT: Public Offering	A: 3000000 MR: - FA: 3.0 million FAN: 3000000	D: 2025-09-04 FD: 2025-09-04	1 investors
7	RT: PIPE (Private Investment in Public Equity) T: - FT: PIPE (Private Investment in Public Equity)	A: 9475000 MR: - FA: 9.475 million FAN: 9475000	D: 2025-08-04 FD: 2025-08-04	1 investors
8	RT: At-the-Market Private Placement T: - FT: At-the-Market Private Placement	A: 1425000 MR: - FA: approximately $1.425 million FAN: 1425000	D: 2025-06-26 FD: 2025-06-26	-

Private Placement Latest

2026-03-30

$11.0M

Private Placement 2026-03-27

$11.0M

Public Offering 2025-10-01

$2.0M

View 7 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

G

Gregory Gorgas

President & Chief Executive Officer

M

Mark Spring

Chief Financial Officer

S

Steven D. Reich

Chief Medical Officer

A

Andy Yates

Senior Vice President, Chief Scientific Officer

S

Saoirse Elizabeth O’Sullivan

Vice President, Translational Sciences

J

Jason Baybutt

Senior Vice President, Finance

View 14 more team members with Pro

Unlock Full Team Directory

Recent News